Haleh Rokni
Mashhad University of Medical Sciences
12 Papers
11 Citations
Haleh Rokni is an academic researcher from Mashhad University of Medical Sciences. The author has contributed to research in topics: Medicine & Vitamin D and neurology. The author has an hindex of 7, co-authored 12 publications. Previous affiliations of Haleh Rokni include University of Manitoba.
Chat about Author
Papers
•Journal Article
Effect of the Three Herbal Extracts on Growth Performance, Immune System, Blood Factors and Intestinal Selected Bacterial Population in Broiler Chickens
TL;DR: The highest and the lowest body weight and weight gain were related to virginiamycin and coneflower, (P 0.05) and garlic significantly reduced the serum levels of cholesterol, LDL, and triglyceride as well as significantly increasing the level of HDL.
Association between serum 25-hydroxyvitamin D concentrations and prevalence of metabolic syndrome
Shokoufeh Bonakdaran,Farzaneh Fakhraee,Maryam Saberi Karimian,Seyed Reza Mirhafez,Haleh Rokni,Mohsen Mohebati,Mohsen Mazidi,Mina Mousavi,Gordon A. Ferns,Majid Ghayour-Mobarhan +9 more
TL;DR: It is found that there is no significant difference in serum 25OHD concentrations between individuals with or without MetS and no significant linear relationship between serum25OHD and several CVD risk factors.
21
Myocardial Cell Signaling During the Transition to Heart Failure: Cellular Signaling and Therapeutic Approaches.
Matthew R. Zeglinski,Adel Rezaei Moghadam,Sudharsana R. Ande,Kimia Sheikholeslami,Kimia Sheikholeslami,Pooneh Mokarram,Zahra Sepehri,Zahra Sepehri,Haleh Rokni,Nima Khadem Mohtaram,Nima Khadem Mohtaram,Mansour Poorebrahim,Anahita Masoom,Mehnosh Toback,Niketa Sareen,Sekaran Saravanan,Sekaran Saravanan,Davinder S. Jassal,Mohammad Hashemi,Hassan Marzban,Dedmer Schaafsma,Pawan K. Singal,Jeffrey T. Wigle,Michael P. Czubryt,Mohsen Akbari,Ian M.C. Dixon,Saeid Ghavami,Saeid Ghavami,Joseph W. Gordon,Sanjiv Dhingra +29 more
TL;DR: This review summarizes the signaling pathways implicated in the transition to HF following cardiac injury and provides an update on cell death signaling and discusses recent advances in cardiac fibrosis as an independent event leading to HF.
18
Simvastatin Treatment Does Not Affect Serum Vitamin D Concentrations in Patients with Dyslipidemia: A Randomized Double-blind Placebo-controlled Cross-over Trial
Mohsen Mazidi,Haleh Rokni,Amirhossein Sahebkar,Akram Mohammadi,Majid Ghayour-Mobarhan,Gordon A. Ferns +5 more
TL;DR: Short-term treatment with simvastatin (40 mg/day) does not have a significant affect on serum levels of Vitamin D as Vitamin D status has an impact on monocyte/macrophage function and may also contribute to cardiovascular risk.
Diabetic CVD – Focus on Vitamin D
Shokoufeh Bonakdaran,Haleh Rokni +1 more
TL;DR: The impacts of vitamin D on the various CVD risk factors are focused on, which reduces vascular calcification and inflammatory processes.
7